Loading…
Potent Analgesic and Anti-inflammatory Activities of 1-Furan-2-yl-3-pyridin-2-yl-propenone With Gastric Ulcer Sparing Effect
Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most frequently prescribed drug for the treatnrent of inflammation and pain. However, conventional NSAIDs and selective COX-2 inhibitors have shown many side effects such as gastric mucosal damage and cardiovascular problems. Recently, the use of...
Saved in:
Published in: | Biological & Pharmaceutical Bulletin 2006, Vol.29 (2), p.361-364 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | Japanese |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 364 |
container_issue | 2 |
container_start_page | 361 |
container_title | Biological & Pharmaceutical Bulletin |
container_volume | 29 |
creator | Eung-Seok LEE Byung Chul PARK Seung-Hwan PAEK Yoon-Seok LEE Arjun BASNET Da-Qing JIN Han-Gon CHOI Chul Soon YONG Jung-Ae KIM |
description | Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most frequently prescribed drug for the treatnrent of inflammation and pain. However, conventional NSAIDs and selective COX-2 inhibitors have shown many side effects such as gastric mucosal damage and cardiovascular problems. Recently, the use of dual acting inhibitors of cyclooxygenases (COX) and lipoxygenase (LOX) has been highlighted for their minimized side effects compared to NSAIDs. The objective of the present study was to examine the efficacy and the gastric side effects of 1-furan-2-yl-3-pyridin-2-yl-propenone (FPP-3), a synthetic dual inhibitor of COX/5-LOX. Indomethacin (1-50 mg/kg, p.o.), a non-selective COX inhibitor, and FPP-3 (0.5-50 mg/kg, p.o.), a dual inhibitor, significantly suppressed the carrageen-induced paw edema with different pharmacological profiles. |
format | article |
fullrecord | <record><control><sourceid>medicalonline</sourceid><recordid>TN_cdi_medicalonline_journals_cs7biolo_2006_002902_030_0361_0364944237</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>cs7biolo_2006_002902_030_0361_0364944237</sourcerecordid><originalsourceid>FETCH-LOGICAL-m1321-785d04f05361eaf0aa97648a55cb9cef93ea4c1f58a8fdb6ca7ecca4e602bed53</originalsourceid><addsrcrecordid>eNotj81KAzEUhWehYP15h7xA4CaZ32UpbRUKClpcDncyNzUlkwxJKhR8eCt2cc7h23xwbooFdKLltajau-I-pSMANCDVovh5C5l8ZkuP7kDJaoZ-vFC23HrjcJowh3hmS53tt82WEguGCb45RfRc8rPjis_naEd7xTmGmXzwxD5t_mJbTDletHunKbL3GaP1B7Y2hnR-LG4NukRP130o9pv1x-qZ7163L6vljk9CScGbthqhNFCpWhAaQOyaumyxqvTQaTKdIiy1MFWLrRmHWmNDWmNJNciBxko9FJt_70Sj1eiCd9ZTfwyneLmdep2awQYXeglQ9wCyA9mDgktq8VdlV5ZSNeoXT4dkdg</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Potent Analgesic and Anti-inflammatory Activities of 1-Furan-2-yl-3-pyridin-2-yl-propenone With Gastric Ulcer Sparing Effect</title><source>Free Full-Text Journals in Chemistry</source><creator>Eung-Seok LEE ; Byung Chul PARK ; Seung-Hwan PAEK ; Yoon-Seok LEE ; Arjun BASNET ; Da-Qing JIN ; Han-Gon CHOI ; Chul Soon YONG ; Jung-Ae KIM</creator><creatorcontrib>Eung-Seok LEE ; Byung Chul PARK ; Seung-Hwan PAEK ; Yoon-Seok LEE ; Arjun BASNET ; Da-Qing JIN ; Han-Gon CHOI ; Chul Soon YONG ; Jung-Ae KIM ; College of Pharmacy ; Yeungnam University</creatorcontrib><description>Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most frequently prescribed drug for the treatnrent of inflammation and pain. However, conventional NSAIDs and selective COX-2 inhibitors have shown many side effects such as gastric mucosal damage and cardiovascular problems. Recently, the use of dual acting inhibitors of cyclooxygenases (COX) and lipoxygenase (LOX) has been highlighted for their minimized side effects compared to NSAIDs. The objective of the present study was to examine the efficacy and the gastric side effects of 1-furan-2-yl-3-pyridin-2-yl-propenone (FPP-3), a synthetic dual inhibitor of COX/5-LOX. Indomethacin (1-50 mg/kg, p.o.), a non-selective COX inhibitor, and FPP-3 (0.5-50 mg/kg, p.o.), a dual inhibitor, significantly suppressed the carrageen-induced paw edema with different pharmacological profiles.</description><identifier>ISSN: 0918-6158</identifier><language>jpn</language><publisher>Pharmaceutical Society of Japan</publisher><ispartof>Biological & Pharmaceutical Bulletin, 2006, Vol.29 (2), p.361-364</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010</link.rule.ids></links><search><creatorcontrib>Eung-Seok LEE</creatorcontrib><creatorcontrib>Byung Chul PARK</creatorcontrib><creatorcontrib>Seung-Hwan PAEK</creatorcontrib><creatorcontrib>Yoon-Seok LEE</creatorcontrib><creatorcontrib>Arjun BASNET</creatorcontrib><creatorcontrib>Da-Qing JIN</creatorcontrib><creatorcontrib>Han-Gon CHOI</creatorcontrib><creatorcontrib>Chul Soon YONG</creatorcontrib><creatorcontrib>Jung-Ae KIM</creatorcontrib><creatorcontrib>College of Pharmacy</creatorcontrib><creatorcontrib>Yeungnam University</creatorcontrib><title>Potent Analgesic and Anti-inflammatory Activities of 1-Furan-2-yl-3-pyridin-2-yl-propenone With Gastric Ulcer Sparing Effect</title><title>Biological & Pharmaceutical Bulletin</title><description>Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most frequently prescribed drug for the treatnrent of inflammation and pain. However, conventional NSAIDs and selective COX-2 inhibitors have shown many side effects such as gastric mucosal damage and cardiovascular problems. Recently, the use of dual acting inhibitors of cyclooxygenases (COX) and lipoxygenase (LOX) has been highlighted for their minimized side effects compared to NSAIDs. The objective of the present study was to examine the efficacy and the gastric side effects of 1-furan-2-yl-3-pyridin-2-yl-propenone (FPP-3), a synthetic dual inhibitor of COX/5-LOX. Indomethacin (1-50 mg/kg, p.o.), a non-selective COX inhibitor, and FPP-3 (0.5-50 mg/kg, p.o.), a dual inhibitor, significantly suppressed the carrageen-induced paw edema with different pharmacological profiles.</description><issn>0918-6158</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNotj81KAzEUhWehYP15h7xA4CaZ32UpbRUKClpcDncyNzUlkwxJKhR8eCt2cc7h23xwbooFdKLltajau-I-pSMANCDVovh5C5l8ZkuP7kDJaoZ-vFC23HrjcJowh3hmS53tt82WEguGCb45RfRc8rPjis_naEd7xTmGmXzwxD5t_mJbTDletHunKbL3GaP1B7Y2hnR-LG4NukRP130o9pv1x-qZ7163L6vljk9CScGbthqhNFCpWhAaQOyaumyxqvTQaTKdIiy1MFWLrRmHWmNDWmNJNciBxko9FJt_70Sj1eiCd9ZTfwyneLmdep2awQYXeglQ9wCyA9mDgktq8VdlV5ZSNeoXT4dkdg</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>Eung-Seok LEE</creator><creator>Byung Chul PARK</creator><creator>Seung-Hwan PAEK</creator><creator>Yoon-Seok LEE</creator><creator>Arjun BASNET</creator><creator>Da-Qing JIN</creator><creator>Han-Gon CHOI</creator><creator>Chul Soon YONG</creator><creator>Jung-Ae KIM</creator><general>Pharmaceutical Society of Japan</general><scope/></search><sort><creationdate>2006</creationdate><title>Potent Analgesic and Anti-inflammatory Activities of 1-Furan-2-yl-3-pyridin-2-yl-propenone With Gastric Ulcer Sparing Effect</title><author>Eung-Seok LEE ; Byung Chul PARK ; Seung-Hwan PAEK ; Yoon-Seok LEE ; Arjun BASNET ; Da-Qing JIN ; Han-Gon CHOI ; Chul Soon YONG ; Jung-Ae KIM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-m1321-785d04f05361eaf0aa97648a55cb9cef93ea4c1f58a8fdb6ca7ecca4e602bed53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>2006</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eung-Seok LEE</creatorcontrib><creatorcontrib>Byung Chul PARK</creatorcontrib><creatorcontrib>Seung-Hwan PAEK</creatorcontrib><creatorcontrib>Yoon-Seok LEE</creatorcontrib><creatorcontrib>Arjun BASNET</creatorcontrib><creatorcontrib>Da-Qing JIN</creatorcontrib><creatorcontrib>Han-Gon CHOI</creatorcontrib><creatorcontrib>Chul Soon YONG</creatorcontrib><creatorcontrib>Jung-Ae KIM</creatorcontrib><creatorcontrib>College of Pharmacy</creatorcontrib><creatorcontrib>Yeungnam University</creatorcontrib><jtitle>Biological & Pharmaceutical Bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eung-Seok LEE</au><au>Byung Chul PARK</au><au>Seung-Hwan PAEK</au><au>Yoon-Seok LEE</au><au>Arjun BASNET</au><au>Da-Qing JIN</au><au>Han-Gon CHOI</au><au>Chul Soon YONG</au><au>Jung-Ae KIM</au><aucorp>College of Pharmacy</aucorp><aucorp>Yeungnam University</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potent Analgesic and Anti-inflammatory Activities of 1-Furan-2-yl-3-pyridin-2-yl-propenone With Gastric Ulcer Sparing Effect</atitle><jtitle>Biological & Pharmaceutical Bulletin</jtitle><date>2006</date><risdate>2006</risdate><volume>29</volume><issue>2</issue><spage>361</spage><epage>364</epage><pages>361-364</pages><issn>0918-6158</issn><abstract>Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most frequently prescribed drug for the treatnrent of inflammation and pain. However, conventional NSAIDs and selective COX-2 inhibitors have shown many side effects such as gastric mucosal damage and cardiovascular problems. Recently, the use of dual acting inhibitors of cyclooxygenases (COX) and lipoxygenase (LOX) has been highlighted for their minimized side effects compared to NSAIDs. The objective of the present study was to examine the efficacy and the gastric side effects of 1-furan-2-yl-3-pyridin-2-yl-propenone (FPP-3), a synthetic dual inhibitor of COX/5-LOX. Indomethacin (1-50 mg/kg, p.o.), a non-selective COX inhibitor, and FPP-3 (0.5-50 mg/kg, p.o.), a dual inhibitor, significantly suppressed the carrageen-induced paw edema with different pharmacological profiles.</abstract><pub>Pharmaceutical Society of Japan</pub><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0918-6158 |
ispartof | Biological & Pharmaceutical Bulletin, 2006, Vol.29 (2), p.361-364 |
issn | 0918-6158 |
language | jpn |
recordid | cdi_medicalonline_journals_cs7biolo_2006_002902_030_0361_0364944237 |
source | Free Full-Text Journals in Chemistry |
title | Potent Analgesic and Anti-inflammatory Activities of 1-Furan-2-yl-3-pyridin-2-yl-propenone With Gastric Ulcer Sparing Effect |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T04%3A46%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-medicalonline&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potent%20Analgesic%20and%20Anti-inflammatory%20Activities%20of%201-Furan-2-yl-3-pyridin-2-yl-propenone%20With%20Gastric%20Ulcer%20Sparing%20Effect&rft.jtitle=Biological%20&%20Pharmaceutical%20Bulletin&rft.au=Eung-Seok%20LEE&rft.aucorp=College%20of%20Pharmacy&rft.date=2006&rft.volume=29&rft.issue=2&rft.spage=361&rft.epage=364&rft.pages=361-364&rft.issn=0918-6158&rft_id=info:doi/&rft_dat=%3Cmedicalonline%3Ecs7biolo_2006_002902_030_0361_0364944237%3C/medicalonline%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-m1321-785d04f05361eaf0aa97648a55cb9cef93ea4c1f58a8fdb6ca7ecca4e602bed53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |